Aarti Industries Ltd
Aarti Industries Ltd, the flagship company of the Aarti group, manufacturing organic and inorganic chemicals at its major facilities in Vapi, Jhagadia, Dahej and Kutch, in Gujarat and in Tarapur in Maharashtra. The company has a strong market position in the NCB-based specialty chemicals segment.[1]
- Market Cap ₹ 18,213 Cr.
- Current Price ₹ 502
- High / Low ₹ 523 / 338
- Stock P/E 34.9
- Book Value ₹ 164
- Dividend Yield 0.20 %
- ROCE 6.85 %
- ROE 7.13 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 3.06 times its book value
- Tax rate seems low
- Company has a low return on equity of 7.11% over last 3 years.
- Company might be capitalizing the interest cost
- Dividend payout has been low at 9.43% of profits over last 3 years
- Debtor days have increased from 50.1 to 61.8 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,890 | 3,006 | 3,163 | 3,806 | 4,168 | 4,186 | 4,506 | 6,086 | 6,619 | 6,371 | 7,271 | 8,286 | 9,010 | |
| 2,424 | 2,434 | 2,509 | 3,106 | 3,202 | 3,209 | 3,525 | 4,365 | 5,530 | 5,393 | 6,271 | 7,119 | 7,675 | |
| Operating Profit | 466 | 572 | 654 | 700 | 965 | 977 | 982 | 1,720 | 1,089 | 978 | 1,000 | 1,167 | 1,335 |
| OPM % | 16% | 19% | 21% | 18% | 23% | 23% | 22% | 28% | 16% | 15% | 14% | 14% | 15% |
| 9 | 6 | 2 | 7 | 2 | 9 | 1 | 1 | 1 | 7 | 16 | 12 | 15 | |
| Interest | 138 | 117 | 117 | 132 | 183 | 125 | 86 | 102 | 168 | 211 | 275 | 340 | 364 |
| Depreciation | 82 | 98 | 123 | 146 | 163 | 185 | 231 | 246 | 310 | 378 | 434 | 474 | 484 |
| Profit before tax | 255 | 363 | 416 | 429 | 622 | 676 | 665 | 1,372 | 611 | 395 | 307 | 365 | 502 |
| Tax % | 24% | 26% | 21% | 19% | 19% | 19% | 19% | 14% | 11% | -5% | -8% | -15% | |
| 208 | 268 | 328 | 346 | 504 | 547 | 535 | 1,186 | 545 | 416 | 331 | 419 | 531 | |
| EPS in Rs | 5.81 | 7.71 | 9.62 | 10.24 | 14.18 | 15.39 | 15.02 | 32.71 | 15.04 | 11.49 | 9.13 | 11.56 | 14.64 |
| Dividend Payout % | 24% | 28% | 3% | 2% | 19% | 11% | 10% | 11% | 17% | 9% | 11% | 9% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 8% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -5% |
| 3 Years: | -9% |
| TTM: | 122% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | -10% |
| 3 Years: | 3% |
| 1 Year: | 34% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 12% |
| 3 Years: | 7% |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 42 | 41 | 41 | 43 | 87 | 87 | 181 | 181 | 181 | 181 | 181 |
| Reserves | 972 | 1,096 | 1,321 | 1,538 | 2,587 | 2,892 | 3,416 | 4,335 | 4,739 | 5,109 | 5,424 | 5,774 |
| 1,202 | 1,292 | 1,564 | 2,083 | 2,401 | 2,098 | 2,857 | 2,587 | 2,907 | 3,623 | 3,848 | 4,966 | |
| 719 | 538 | 573 | 730 | 826 | 1,256 | 1,282 | 748 | 754 | 1,203 | 1,661 | 2,378 | |
| Total Liabilities | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 10,115 | 11,114 | 13,299 |
| 967 | 1,246 | 1,697 | 1,998 | 2,147 | 2,468 | 3,593 | 3,595 | 4,861 | 5,649 | 6,377 | 6,556 | |
| CWIP | 193 | 313 | 270 | 436 | 795 | 1,418 | 1,298 | 1,346 | 1,096 | 1,229 | 1,454 | 2,030 |
| Investments | 139 | 41 | 47 | 47 | 33 | 37 | 64 | 28 | 17 | 23 | 48 | 132 |
| 1,639 | 1,366 | 1,486 | 1,910 | 2,884 | 2,409 | 2,688 | 2,882 | 2,607 | 3,214 | 3,235 | 4,581 | |
| Total Assets | 2,938 | 2,966 | 3,499 | 4,391 | 5,858 | 6,332 | 7,642 | 7,851 | 8,581 | 10,115 | 11,114 | 13,299 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 340 | 574 | 470 | 335 | 736 | 1,102 | 873 | 519 | 1,319 | 1,210 | 1,242 | 775 | |
| -298 | -452 | -529 | -610 | -797 | -1,124 | -1,322 | -1,169 | -1,330 | -1,369 | -1,398 | -1,141 | |
| -23 | -128 | 58 | 279 | 833 | -535 | 614 | 412 | 38 | 420 | -73 | 745 | |
| Net Cash Flow | 19 | -7 | -0 | 4 | 772 | -557 | 165 | -239 | 27 | 261 | -229 | 379 |
| Free Cash Flow | 45 | 124 | -60 | -279 | -55 | -23 | -442 | -646 | -8 | -96 | -137 | -346 |
| CFO/OP | 85% | 117% | 87% | 62% | 90% | 130% | 99% | 44% | 129% | 132% | 123% | 67% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 64 | 61 | 63 | 68 | 66 | 64 | 65 | 52 | 49 | 39 | 62 |
| Inventory Days | 123 | 108 | 136 | 144 | 152 | 174 | 190 | 143 | 115 | 121 | 126 | 118 |
| Days Payable | 55 | 67 | 71 | 69 | 55 | 72 | 117 | 53 | 24 | 76 | 107 | 126 |
| Cash Conversion Cycle | 123 | 105 | 125 | 138 | 165 | 168 | 137 | 155 | 143 | 94 | 58 | 54 |
| Working Capital Days | 10 | 10 | -4 | 6 | -14 | -14 | -36 | 22 | -29 | -36 | -44 | -64 |
| ROCE % | 19% | 20% | 19% | 16% | 18% | 15% | 13% | 22% | 10% | 7% | 6% | 7% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Export Share of Revenue % |
|
|||||||||
| Manufacturing Plants count |
||||||||||
| DCB Capacity Utilization % |
||||||||||
| MMA Production Volume kT |
||||||||||
| NCB Capacity Utilization % |
||||||||||
| Energy Application Revenue Share % |
||||||||||
| MMA Capacity Utilization % |
||||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Aarti Industries will attend investor meets in Singapore and Hong Kong on August 11-14, 2026.
-
Submission Of Reclassification Application To Stock Exchanges
- Aarti Industries submitted reclassification application for Mrs. Ratanben Premji Gogri from promoter to public on August 3, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Please find attached Newspaper Publication for Unaudited Financial Results
-
Updates On Risk Management Committee
- Risk Management Committee renamed ESG Committee; Nikhil J. Bhatia inducted effective July 30, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
Jul 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
Aug 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023Transcript PPT REC
-
Mar 2023TranscriptAI SummaryPPT
-
Mar 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Sep 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021Transcript PPT
-
Sep 2021TranscriptAI SummaryPPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
-
Jan 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
May 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jul 2019TranscriptAI SummaryPPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Nov 2017TranscriptPPT
-
Aug 2017TranscriptPPT
-
Jun 2017Transcript PPT
-
Mar 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Aug 2016TranscriptPPT
-
Jun 2016Transcript PPT
-
Apr 2016TranscriptAI SummaryPPT
-
Mar 2016TranscriptAI SummaryPPT
-
Mar 2016TranscriptAI SummaryPPT
-
Feb 2016Transcript PPT
-
Jan 2016TranscriptAI SummaryPPT
Product Portfolio[1]
The company’s key product value chains include Nitro Chloro Benzenes (NCB), Di-Chloro Benzenes (DCB), Phenylenediamines (PDA), Nitro Toluene derivatives, and Sulphuric Acid & downstream products, with a portfolio of over 100 products.